지씨플루주(인플루엔자분할백신)

(주

Manufacturer · Finished Dosage FormsRepublic of Korea

Basic Information

2

Category

Finished Dosage Forms

Subcategory & Sub-subcategory

Injectables & Parenterals / Small Volume Parenterals (SVP)

Trade Type

Sell

Product Name

지씨플루주(인플루엔자분할백신)

Details

Purified influenza virus antigen A • Michigan • 105 • 2025 SAN-049A • Purified influenza virus antigen B • Tokyo • EIS13-175 • 2025 • Purified Inactivated Influenza Virus Antigen A [A/Singapore/GP20238/2024 IVR-277(H3N2)] • Purified Inactivated Influenza Virus Antigen A [A/Switzerland/6849/2025 IVR-278(H1N1)] • Purified Influenza Virus Antigen B type(Split virion/Inactivated)[B/Austria/1359417/2021/BVR-26]

Substance

Purified influenza virus antigen A • Michigan • 105 • 2025 SAN-049A • Purified influenza virus antigen B • Tokyo • EIS13-175 • 2025 • Purified Inactivated Influenza Virus Antigen A [A/Singapore/GP20238/2024 IVR-277(H3N2)] • Purified Inactivated Influenza Virus Antigen A [A/Switzerland/6849/2025 IVR-278(H1N1)] • Purified Influenza Virus Antigen B type(Split virion/Inactivated)[B/Austria/1359417/2021/BVR-26]

Registered Market

Republic of Korea

Specifications

Dosage Form: Injection

Documents

Drug Marketing Authorization Number

Document No.: 557

Issue Date: Jul 22, 2009

Ratings

(0)

(0)

(0)

(0)

(0)

Leave your rating & comment

Comments

Filters:

Sort by:

No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Similar Products & Services

Products & Services related to what you're viewing

People Also Viewed

Other products & services viewed by people who looked at this product